Preventing or delaying the onset of Type 2 diabetes and related complications and illnesses will reduce long term treatment costs.
Type 2 diabetes prevalence is increasing rapidly and is estimated to reach five million in the UK by 2025; with Type 2 diabetes related costs to the NHS estimated to reach £17 billion by 2035. This presents a major public health challenge.
The NHS Diabetes Prevention Programme (NHS DPP) was announced in the NHS Five Year Forward View. The programme, which is a joint initiative between NHS England, Public Health England (PHE) and Diabetes UK, aims to significantly reduce the four million people in England otherwise expected to have Type 2 diabetes by 2025. It could save lives in the future and millions of pounds for the NHS.
SPHR’s academic partners Fuse and MRC Cambridge are evaluating the first phase of the NHS DPP in preparation for implementation.
This early evaluation will provide evidence from sites across England on maximising implementation and effectiveness and identifying opportunities to evaluate nationally.
TagsChanging behaviour at population levelDiabetesEfficient & equitable health systems